Form 4 for DNA Ginkgo Bioworks Holdings, Inc.
Accepted 2022-12-09 00:00:00 ET · period of report 2022-12-07 · accession 0001127602-22-027221 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-12-09 | 2022-12-07+ | DNA | Kelly Jason R | See remarks, Dir | S - Sale | $1.74 | -198.1K | 19.61M | -1% | -$344.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-12-07 | S | D | 100,909 | $1.69 | 19,708,432 | D | — | — | |
| 2 | Common | Class A Common Stock | 2022-12-08 | S | D | 97,204 | $1.79 | 19,611,228 | D | — | — |